Lynderm Research Inc /ID# 267006

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Atopic dermatitis (eczema)

Running trials

• Active, not recruiting

  A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

  NCT06461897· Phase 3· AbbVie· Source